Farnesoid X receptor activation inhibits TGFBR1/TAK1-mediated vascular inflammation and calcification via miR-135a-5p
Open Access
- 24 June 2020
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 3 (1) , 1-15
Abstract
Chronic inflammation plays a crucial role in vascular calcification. However, only a few studies have revealed the mechanisms underlying the development of inflammation under high-phosphate conditions in chronic kidney disease (CKD) patients. Here, we show that inflammation resulting from the activation of the TGFBR1/TAK1 pathway is involved in calcification in CKD rats or osteogenic medium-cultured human aortic smooth muscle cells (HASMCs). Moreover, miR-135a-5p is demonstrated to be a key regulator of the TGFBR1/TAK1 pathway, which has been reported to be decreased in CKD rats. We further reveal that farnesoid X receptor (FXR) activation increases miR-135a-5p expression, thereby inhibiting the activation of the TGFBR1/TAK1 pathway, ultimately resulting in the attenuation of vascular inflammation and calcification in CKD rats. Our findings provide advanced insights into the mechanisms underlying the development of inflammation in vascular calcification, and evidence that FXR activation could serve as a therapeutic strategy for retarding vascular calcification in CKD patients.Keywords
Funding Information
- National Natural Science Foundation of China (81774242)
- Taishan Scholar Foundation of Shandong Province (ts201712042)
This publication has 59 references indexed in Scilit:
- Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expressionKidney International, 2012
- Calcified Atherosclerosis in Different Vascular Beds and the Risk of MortalityArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Transforming growth factor (TGF)-β signaling in cardiac remodelingJournal of Molecular and Cellular Cardiology, 2011
- miR-125b Regulates Calcification of Vascular Smooth Muscle CellsThe American Journal of Pathology, 2011
- The Regulation of Valvular and Vascular Sclerosis by Osteogenic MorphogensCirculation Research, 2011
- Runx2-Upregulated Receptor Activator of Nuclear Factor κB Ligand in Calcifying Smooth Muscle Cells Promotes Migration and Osteoclastic Differentiation of MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Farnesoid X Receptor Activation Prevents the Development of Vascular Calcification in ApoE −/− Mice With Chronic Kidney DiseaseCirculation Research, 2010
- Vascular CalcificationJournal of the American Society of Nephrology, 2009
- Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemiaJournal of Lipid Research, 2009
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992